AtaiBeckley Announces Positive Topline Data from the Phase 2b Open-Label Extension Study of BPL-003, Supporting Safety and Efficacy of a Second Dose in Pati…

A 12 mg dose of BPL-003 (mebufotenin benzoate nasal spray) administered eight weeks after an initial 12 mg, 8 mg or 0.3 mg ...
Scientific Research Publishing

Analysis of Decision Support Systems (DSS) Integration with AI Using Mobile Health (m-Health) and Wearables ()

Wearables, Mobile Health (m-Health), Real-Time Monitoring Share and Cite: Alqarni, A. (2025) Analysis of Decision Support ...
Pharmaceutical Commerce

Pharma Pulse: HHS Updates Menopausal Hormone Therapy Labels, as SGLT2 Inhibitors Show Broader Kidney and Heart Benefits

This episode of Pharma Pulse explores how regulators modernize safety information for hormone therapy, new data that ...